1921
Volume 91, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Dengue is the most significant arthropod-borne viral infection of humans. Persons infected with dengue viruses (DENV) have subclinical or clinically apparent infections ranging from undifferentiated fever to dengue hemorrhagic fever/shock syndrome. Although recent studies estimated that the Indian subcontinent has the greatest burden of DENV infection and disease worldwide, we do not have reliable, population-based estimates of the incidence of infection and disease in this region. The goal of this study was to follow-up a cohort of 800 children living in a heavily urbanized area of Colombo, Sri Lanka to obtain accurate estimates of the incidence of DENV infection and disease. Annual blood samples were obtained from all children to estimate dengue seroprevalence at enrollment and to identify children exposed to new DENV infections during the study year. Blood was also obtained from any child in whom fever developed over the course of the study year to identify clinically apparent DENV infections. At enrollment, dengue seroprevalence was 53.07%, which indicated high transmission in this population. Over the study year, the incidence of DENV infection and disease were 8.39 (95% confidence interval = 6.56–10.53) and 3.38 (95% confidence interval = 2.24–4.88), respectively, per 100 children per year. The ratio of clinically inapparent to apparent infections was 1.48. These results will be useful for obtaining more accurate estimates of the burden of dengue in the region and for making decisions about testing and introduction of vaccines.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.13-0540
2014-07-02
2017-09-23
Loading full text...

Full text loading...

/deliver/fulltext/14761645/91/1/132.html?itemId=/content/journals/10.4269/ajtmh.13-0540&mimeType=html&fmt=ahah

References

  1. Wahala WM, Silva AM, , 2011. The human antibody response to dengue virus infection. Viruses 3: 23742395.[Crossref]
  2. Halstead SB, , 2007. Dengue. Lancet 370: 16441652.[Crossref]
  3. Rothman AL, , 2011. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 11: 532543.[Crossref]
  4. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI, , 2013. The global distribution and burden of dengue. Nature 496: 504507.[Crossref]
  5. Endy TP, Anderson KB, Nisalak A, Yoon IK, Green S, Rothman AL, Thomas SJ, Jarman RG, Libraty DH, Gibbons RV, , 2011. Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand. PLoS Negl Trop Dis 5: e975.[Crossref]
  6. Endy TP, Chunsuttiwat S, Nisalak A, Libraty DH, Green S, Rothman AL, Vaughn DW, Ennis FA, , 2002. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 156: 4051.[Crossref]
  7. Vong S, Goyet S, Ly S, Ngan C, Huy R, Duong V, Wichmann O, Letson GW, Margolis HS, Buchy P, , 2012. Under-recognition and reporting of dengue in Cambodia: a capture-recapture analysis of the National Dengue Surveillance System. Epidemiol Infect 140: 491499.[Crossref]
  8. Yoon IK, Rothman AL, Tannitisupawong D, Srikiatkhachorn A, Jarman RG, Aldstadt J, Nisalak A, Mammen MP, Jr Thammapalo S, Green S, Libraty DH, Gibbons RV, Getis A, Endy T, Jones JW, Koenraadt CJ, Morrison AC, Fansiri T, Pimgate C, Scott TW, , 2012. Underrecognized mildly symptomatic viremic dengue virus infections in rural Thai schools and villages. J Infect Dis 206: 389398.[Crossref]
  9. Sabchareon A, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, Jiwariyavej V, Dulyachai W, Pengsaa K, Margolis HS, Letson GW, , 2012. Dengue infection in children in Ratchaburi, Thailand: a cohort study. I. Epidemiology of symptomatic acute dengue infection in children, 2006–2009. PLoS Negl Trop Dis 6: e1732.[Crossref]
  10. Tien NT, Luxemburger C, Toan NT, Pollissard-Gadroy L, Huong VT, Van Be P, Rang NN, Wartel TA, Lang J, , 2010. A prospective cohort study of dengue infection in schoolchildren in Long Xuyen, Viet Nam. Trans R Soc Trop Med Hyg 104: 592600.[Crossref]
  11. Balmaseda A, Standish K, Mercado JC, Matute JC, Tellez Y, Saborio S, Hammond SN, Nunez A, Aviles W, Henn MR, Holmes EC, Gordon A, Coloma J, Kuan G, Harris E, , 2010. Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua. J Infect Dis 201: 514.[Crossref]
  12. Morrison AC, Minnick SL, Rocha C, Forshey BM, Stoddard ST, Getis A, Focks DA, Russell KL, Olson JG, Blair PJ, Watts DM, Sihuincha M, Scott TW, Kochel TJ, , 2010. Epidemiology of dengue virus in Iquitos, Peru 1999 to 2005: interepidemic and epidemic patterns of transmission. PLoS Negl Trop Dis 4: e670.[Crossref]
  13. Ramos MM, Arguello DF, Luxemburger C, Quinones L, Munoz JL, Beatty M, Lang J, Tomashek KM, , 2008. Epidemiological and clinical observations on patients with dengue in Puerto Rico: results from the first year of enhanced surveillance, June 2005–May 2006. Am J Trop Med Hyg 79: 123127.
  14. Vitarana T, Mackenzie JS, , 1982. Viral diseases in Sri Lanka: a national overview. , ed. Viral Diseases in Southeast Asia and the Western Pacific. London: Academic Press, 198204.
  15. Messer WB, Vitarana UT, Sivananthan K, Elvtigala J, Preethimala LD, Ramesh R, Withana N, Gubler DJ, De Silva AM, , 2002. Epidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic fever. Am J Trop Med Hyg 66: 765773.
  16. Tam CC, Tissera H, de Silva AM, De Silva AD, Margolis HS, Amarasinge A, , 2013. Estimates of dengue force of infection in children in Colombo, Sri Lanka. PLoS Negl Trop Dis 7: e2259.[Crossref]
  17. Kanakaratne N, Wahala WM, Messer WB, Tissera HA, Shahani A, Abeysinghe N, de-Silva AM, Gunasekera M, , 2009. Severe dengue epidemics in Sri Lanka, 2003–2006. Emerg Infect Dis 15: 192199.[Crossref]
  18. Messer WB, Gubler DG, Harris E, Sivananthan K, de Silva AM, , 2003. Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis 9: 800809.[Crossref]
  19. Tissera HA, Ooi EE, Gubler DJ, Tan Y, Logendra B, Wahala WM, de Silva AM, Abeysinghe MR, Palihawadana P, Gunasena S, Tam CC, Amarasinghe A, Letson GW, Margolis HS, De Silva AD, , 2011. New dengue virus type 1 genotype in Colombo, Sri Lanka. Emerg Infect Dis 17: 20532055.[Crossref]
  20. Chakravarti A, Arora R, Luxemburger C, , 2012. Fifty years of dengue in India. Trans R Soc Trop Med Hyg 106: 273282.[Crossref]
  21. Raheel U, Faheem M, Riaz MN, Kanwal N, Javed F, Zaidi N, Qadri I, , 2011. Dengue fever in the Indian subcontinent: an overview. J Infect Dev Ctries 5: 239247.
  22. Anonymous, 2001. Population and Housing Data, City of Colombo (Colombo Municipal Council), Sri Lanka. Census of Population and Housing 2001. Colombo, Sri Lanka: Census Department.
  23. Tissera HA, Amarasinghe A, De Silva AM, Tam CC, De Silva AD, Letson GW, Margolis HS, , 2013. Surveillance of Dengue in a Community Cohort in Metropolitan Colombo, Sri Lanka: Methods and Study Population. Geneva: World Health Organization, Bulletin 91.
  24. Snijdewind IJ, van Kampen JJ, Fraaij PL, van der Ende ME, Osterhaus AD, Gruters RA, , 2012. Current and future applications of dried blood spots in viral disease management. Antiviral Res 93: 309321.[Crossref]
  25. Balmaseda A, Saborio S, Tellez Y, Mercado JC, Perez L, Hammond SN, Rocha C, Kuan G, Harris E, , 2008. Evaluation of immunological markers in serum, filter-paper blood spots, and saliva for dengue diagnosis and epidemiological studies. J Clin Virol 43: 287291.[Crossref]
  26. Wahala WM, Kraus AA, Haymore LB, Accavitti-Loper MA, de Silva AM, , 2009. Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody. Virology 392: 103113.[Crossref]
  27. Anders KL, Nguyet NM, Quyen NT, Ngoc TV, Tram TV, Gan TT, Tung NT, Dung NT, Chau NV, Wills B, Simmons CP, , 2012. An evaluation of dried blood spots and oral swabs as alternative specimens for the diagnosis of dengue and screening for past dengue virus exposure. Am J Trop Med Hyg 87: 165170.[Crossref]
  28. Kuno G, Gomez I, Gubler DJ, , 1987. Detecting artificial anti-dengue IgM immune complexes using an enzyme-linked immunosorbent assay. Am J Trop Med Hyg 36: 153159.
  29. Chungue E, Marche G, Plichart R, Boutin JP, Roux J, , 1989. Comparison of immunoglobulin G enzyme-linked immunosorbent assay (IgG-ELISA) and haemagglutination inhibition (HI) test for the detection of dengue antibodies. Prevalence of dengue IgG-ELISA antibodies in Tahiti. Trans R Soc Trop Med Hyg 83: 708711.[Crossref]
  30. Kraus AA, Messer W, Haymore LB, de Silva AM, , 2007. Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization. J Clin Microbiol 45: 37773780.[Crossref]
  31. Beatty ME, Stone A, Fitzsimons DW, Hanna JN, Lam SK, Vong S, Guzman MG, Mendez-Galvan JF, Halstead SB, Letson GW, Kuritsky J, Mahoney R, Margolis HS, , 2010. Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards. PLoS Negl Trop Dis 4: e890.[Crossref]
  32. Wichmann O, Yoon IK, Vong S, Limkittikul K, Gibbons RV, Mammen MP, Ly S, Buchy P, Sirivichayakul C, Buathong R, Huy R, Letson GW, Sabchareon A, , 2011. Dengue in Thailand and Cambodia: an assessment of the degree of underrecognized disease burden based on reported cases. PLoS Negl Trop Dis 5: e996.[Crossref]
  33. Thai KT, Binh TQ, Giao PT, Phuong HL, Hung LQ, Nam NV, Nga TT, Groen J, Nagelkerke N, de Vries PJ, , 2005. Seroprevalence of dengue antibodies, annual incidence and risk factors among children in southern Vietnam. Trop Med Int Health 10: 379386.[Crossref]
  34. Tran HP, Adams J, Jeffery JA, Nguyen YT, Vu NS, Kutcher SC, Kay BH, Ryan PA, , 2010. Householder perspectives and preferences on water storage and use, with reference to dengue, in the Mekong Delta, southern Vietnam. In Health 2: 136142.[Crossref]
  35. Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, Jiwariyavej V, Dulyachai W, Pengsaa K, Wartel TA, Moureau A, Saville M, Bouckenooghe A, Viviani S, Tornieporth NG, Lang J, , 2012. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet 380: 15591567.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.13-0540
Loading
/content/journals/10.4269/ajtmh.13-0540
Loading

Data & Media loading...

Supplementary Data

Supplementary PDF

  • Received : 18 Sep 2013
  • Accepted : 04 Feb 2014

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error